From target selection to the minimum acceptable biological effect level for human study: use of mechanism-based PK/PD modeling to design safe and efficacious biologics. [electronic resource]
- The AAPS journal Jun 2011
- 169-78 p. digital
Publication Type: Journal Article
1550-7416
10.1208/s12248-011-9256-y doi
Animals Antibodies, Monoclonal--administration & dosage Cytomegalovirus--immunology Dose-Response Relationship, Drug Drug Delivery Systems Drug Design Feasibility Studies Glycoproteins--immunology Humans Immunologic Factors--administration & dosage Macaca fascicularis Models, Biological Species Specificity Translational Research, Biomedical--methods